LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 65 of 166
Next
>>
>
1601 to 1625 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Mean Relative Cell Count	Standard Error of the Mean for Relative Cell Count	Mean Normalized Growth Rate Inhibition Value	Standard Error of the Mean for Normalized Growth Rate Inhibition Value
MDA-MB-231	Sirolimus	3.33	uM	LJP6	0.8043	0.0324	0.7842	0.0407
MDA-MB-231	Sirolimus	10	uM	LJP6	0.8189	0.0388	0.7996	0.0501
MDA-MB-231	ZSTK474	0.04	uM	LJP6	0.8914	0.0298	0.8815	0.0360
MDA-MB-231	ZSTK474	0.12	uM	LJP6	0.8431	0.0238	0.8282	0.0317
MDA-MB-231	ZSTK474	0.37	uM	LJP6	0.7556	0.0061	0.7282	0.0143
MDA-MB-231	ZSTK474	1.11	uM	LJP6	0.6888	0.0235	0.6464	0.0354
MDA-MB-231	ZSTK474	3.33	uM	LJP6	0.5851	0.0236	0.5112	0.0443
MDA-MB-231	ZSTK474	10	uM	LJP6	0.4967	0.0344	0.3855	0.0658
MDA-MB-231	BX-912	0.04	uM	LJP5	0.9090	0.0063	0.9033	0.0057
MDA-MB-231	BX-912	0.12	uM	LJP5	0.9083	0.0429	0.9015	0.0479
MDA-MB-231	BX-912	0.37	uM	LJP5	0.7412	0.1423	0.6938	0.1835
MDA-MB-231	BX-912	1.11	uM	LJP5	0.5114	0.0873	0.4042	0.1333
MDA-MB-231	BX-912	3.33	uM	LJP5	0.3697	0.0420	0.1939	0.0779
MDA-MB-231	BX-912	10	uM	LJP5	0.2595	0.0751	-0.0228	0.1548
MDA-MB-231	Selumetinib	0.04	uM	LJP6	0.8588	0.0389	0.8461	0.0450
MDA-MB-231	Selumetinib	0.12	uM	LJP6	0.7329	0.0491	0.7016	0.0558
MDA-MB-231	Selumetinib	0.37	uM	LJP6	0.6090	0.0460	0.5454	0.0508
MDA-MB-231	Selumetinib	1.11	uM	LJP6	0.5445	0.0354	0.4580	0.0392
MDA-MB-231	Selumetinib	3.33	uM	LJP6	0.4764	0.0292	0.3596	0.0389
MDA-MB-231	Selumetinib	10	uM	LJP6	0.3753	0.0187	0.1998	0.0476
MDA-MB-231	MK2206	0.04	uM	LJP6	0.9703	0.0204	0.9678	0.0227
MDA-MB-231	MK2206	0.12	uM	LJP6	0.9090	0.0226	0.9037	0.0227
MDA-MB-231	MK2206	0.37	uM	LJP6	0.8343	0.0303	0.8214	0.0289
MDA-MB-231	MK2206	1.11	uM	LJP6	0.8208	0.0351	0.8056	0.0352
MDA-MB-231	MK2206	3.33	uM	LJP6	0.7794	0.0292	0.7569	0.0297

|<
<<
Previous
Page 65 of 166
Next
>>
>
1601 to 1625 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)